Ray Hill

Raymond George Hill currently works at Avilex Pharma ApS, as Chairman, Addex Therapeutics Ltd., as Non-Executive Director from 2015, The Research Board, Inc., as Member, and Royal Pharmaceutical Society, as Member.
Dr. Hill also formerly worked at Merck & Co., Inc., as Chairman in 2008, British Pharmacological Society, as President & Chairman-Trustees Council from 2011 to 2012, Orexo AB, as Independent Director from 2008 to 2019, Lectus Therapeutics Ltd., as Non-Executive Director, Addex Therapeutics Ltd., as Non-Executive Director from 2010 to 2013, Merck Sharp & Dohme Research Laboratories, as Executive Director-Licensing & External Research from 2002 to 2008, Covagen AG, as Director-Supervisory Board, Merck Sharp & Dohme Corp., as Executive Director from 1990 to 2008, Karolinska Development AB, as Director in 2011, SKF (U.K.) Ltd., as Group Director-Pharmacology, Neuroscience Research Centre, as Executive Director-Pharmacology from 1990 to 2002, Asceneuron SA, as Independent Director, the University of Cambridge, as Member-Park Davis Research Unit, and Academy of Medical Sciences, as Council Member in 2013.
Dr. Hill received his undergraduate degree and doctorate degree from the University of London.